Aug 2026 (Q3 FY26) — Sep 24, 2026
TD SYNNEX Q3 FY26 — Record Quarter Driven by Broad-Based Growth and AI Demand
Read the full callTD Synnex (SNX) earnings
- Aug 2026
- Aug 2026 (Q3 FY26)
- Nov 2025
TD Synnex earnings: last reported Thu, 24 Sep 2026, for the quarter ended Aug 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 21,558 | +37.7% YoY | Quarterly, as filed | Quarter to Aug 2026 | Revenue from operations as filed. |
| Operating margin | 3.0 | +0.5 pts YoY | Operating profit / revenue | Quarter to Aug 2026 | For the quarter; a change is in percentage points. |
| Net profit | 416 | +83.5% YoY | Quarterly, as filed | Quarter to Aug 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
14 of 17 judged targets kept · 25 open · verdicts reflect calls analysed to May 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Gross billings | approximately $25.1 billion, plus or minus $500 million (~16% growth at midpoint) | Feb 2026 | Our non-GAAP gross billings for the second quarter was $28.9 billion, increasing 33% year-over-year or 32% year-over-year in constant currency and exceeding the high end of our guidance range | Achieved |
| Gross billings | approximately $27.7 billion, plus or minus $500 million (~22% growth at midpoint) | May 2026 | we expect non-GAAP gross billings of approximately $27.7 billion, plus or minus $500 million, up approximately 22% at the midpoint | New |
3 of TD SYNNEX CORP's 42 targets were missed. See which ones, and which are quietly gone. The 2 above are the free sample; 40 more targets are in the full ledger.
Claimed
- Non-GAAP gross billings reached $31.8 billion, up 40% year-over-year, exceeding guidance.
- Non-GAAP EPS was $5.68, up 59% year-over-year, above guidance range.
- Distribution non-GAAP gross billings increased 27% to $24.8 billion with double-digit growth across all regions.
- Hyve non-GAAP gross billings increased 117% to $7 billion, exceeding expectations.
- Non-GAAP operating income grew 55% year-over-year to $736 million, with operating margin expanding 35 basis points in Distribution.
Qualified
- Free cash flow consumption for the quarter was approximately $1 billion, driven by increased inventory in Hyve's supply chain business and new customer programs.
- Hyve's non-GAAP operating margin as a percentage of gross billings was 3.61%, down from 5.04% in the prior year period, due to mix headwinds from large AI rack programs.
Price
$248.57 +0.74% · +$1.82
Performance +62.2% 1Y
1Y: $153.21 on 17 Oct 2025 → $248.57. High $290.14 (23 Jun 2026), low $142.42 (20 Nov 2025).
- Previous close
- $246.75
- 52-week range
- $142.42 – $290.14
- One year
- +60.37%
Overview
- Symbol
- SNX
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
14 of 17 judged targets kept · 25 open · verdicts reflect calls analysed to May 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Gross billings | approximately $25.1 billion, plus or minus $500 million (~16% growth at midpoint) | Feb 2026 | Our non-GAAP gross billings for the second quarter was $28.9 billion, increasing 33% year-over-year or 32% year-over-year in constant currency and exceeding the high end of our guidance range | Achieved |
| Gross billings | approximately $27.7 billion, plus or minus $500 million (~22% growth at midpoint) | May 2026 | we expect non-GAAP gross billings of approximately $27.7 billion, plus or minus $500 million, up approximately 22% at the midpoint | New |
Claimed
- Non-GAAP gross billings reached $31.8 billion, up 40% year-over-year, exceeding guidance.
- Non-GAAP EPS was $5.68, up 59% year-over-year, above guidance range.
- Distribution non-GAAP gross billings increased 27% to $24.8 billion with double-digit growth across all regions.
- Hyve non-GAAP gross billings increased 117% to $7 billion, exceeding expectations.
- Non-GAAP operating income grew 55% year-over-year to $736 million, with operating margin expanding 35 basis points in Distribution.
Qualified
- Free cash flow consumption for the quarter was approximately $1 billion, driven by increased inventory in Hyve's supply chain business and new customer programs.
- Hyve's non-GAAP operating margin as a percentage of gross billings was 3.61%, down from 5.04% in the prior year period, due to mix headwinds from large AI rack programs.
The full ledger
Open TD SYNNEX CORP’s full ledger
A free account opens 5 company ledgers a month. All 42 tracked commitments, with each call’s wording and source.
Call summaries
May 2026 (Q2 FY26) — Jun 25, 2026
TD SYNNEX Q2 FY26 — Record Growth Driven by Distribution Strength and Hyve Hyperscaler Ramps
Read the full callFeb 2026 (Q1 FY26) — Mar 31, 2026
TD SYNNEX Q1 FY26 — Record Billings and EPS Driven by Distribution and Hyve Strength
Read the full callNews
Latest news
From the news desk, item by item, hours after each call.
Every analysed call
TD Synnex earnings calls (SNX)
Financials
What the filings say
Net profit, year on year: +84% (quarter to aug 2026 against aug 2025).
| Line item | Nov 2024 | Feb 2025 | May 2025 | Aug 2025 | Nov 2025 | Feb 2026 | May 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 15,845 | 14,532 | 14,946 | 15,651 | 17,379 | 17,161 | 19,575 | 21,558 |
| Operating profit | 325 | 304 | 328 | 384 | 399 | 489 | 519 | 643 |
| Operating margin | 2.0% | 2.1% | 2.2% | 2.5% | 2.3% | 2.9% | 2.6% | 3.0% |
| Interest | — | -88 | -90 | -91 | 626 | -87 | -98 | -121 |
| Profit before tax | 237 | 215 | 238 | 293 | 311 | 422 | 430 | 555 |
| Tax rate | 17.9% | 22.0% | 22.3% | 22.7% | 20.1% | 22.6% | 22.3% | 25.0% |
| Net profit | 195 | 168 | 185 | 227 | 248 | 327 | 334 | 416 |
| EPS ($ per share) | — | 1.98 | 2.22 | 2.76 | — | 4.05 | 4.16 | 5.20 |
| Line item | Nov 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 2,199 | 2,625 | 3,133 | 1,172 | 1,708 | 2,205 | 2,756 | 3,437 |
| Total liabilities | 8,108 | 7,910 | 9,130 | 19,760 | 21,708 | 21,230 | 22,239 | 25,800 |
| Fixed assets | 571 | 570 | 158 | 483 | 421 | 450 | 457 | 496 |
| Investments | 3 | — | — | — | — | — | — | — |
| Total assets | 11,543 | 11,698 | 13,469 | 27,666 | 29,734 | 29,413 | 30,274 | 34,251 |
| Line item | Nov 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 101 | 550 | 1,834 | 810 | -50 | 1,407 | 1,218 | 1,532 |
| Cash from investing | -1,180 | -147 | -209 | -952 | -116 | -156 | -194 | -221 |
| Cash from financing | 1,001 | -632 | -292 | -393 | -276 | -786 | -953 | -33 |
| Net cash flow | -95 | -231 | 1,338 | -574 | -472 | 511 | 26 | 1,376 |
| Capital expenditure | -125 | -137 | -27 | -40 | -65 | -150 | -175 | -142 |
| Free cash flow | -25 | 412 | 1,808 | 770 | -115 | 1,257 | 1,043 | 1,389 |
SNX revenue by segment
Europe Distribution shrank from 36% to 30% of revenue over the last three quarters.
| Segment | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|
| Americas Distribution | 45% | 49% | 48% | — |
| Europe Distribution | 36% | 31% | 30% | — |
| Hyve Solutions | 13% | 15% | 18% | — |
| APJ Distribution | 6% | 5% | 5% | — |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Revenue by region
Q4 FY2025 · share of revenue
- Americas 55% ↓ 2 pt
- Europe 37% ↑ 1 pt
As SNX cuts its regions in its filings; they can nest, so they need not add to 100%.
Insider filings
174 filings between Oct 21, 2025 and Oct 15, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$40.71M
137 sales by 9 insiders
85% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 13
- Award — granted as compensation
- 10
- Option exercise — converted options into shares
- 14
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| HUME RICHARD T | — | $19.25M | Aug 5, 2026 |
| POLK DENNIS | — | $15.40M | Oct 15, 2026 |
| Zammit Patrick | — | $2.38M | Feb 6, 2026 |
| Saintil Merline | — | $1.11M | May 4, 2026 |
| Murphy Miriam Anne | — | $867.2K | Apr 9, 2026 |
| Jordan David Gregory | — | $611.0K | Apr 6, 2026 |
| Thompson Reyna | — | $490.7K | Apr 29, 2026 |
| VEZINA ANN F | — | $326.0K | Jul 31, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 648 | $163.0K |
| Oct 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 200 | $50.7K |
| Oct 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 5 | $1.3K |
| Oct 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 295 | $75.1K |
| Oct 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 300 | $74.9K |
| Oct 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 600 | $150.3K |
| Oct 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 452 | $114.1K |
| Oct 5, 2026 | Henry John Paul Chief Accounting Officer | Tax withheld | 172 | $47.7K |
| Oct 5, 2026 | POLK DENNIS Chair, Hyve Solutions | Tax withheld | 764 | $211.8K |
| Oct 5, 2026 | Zammit Patrick Chief Executive Officer | Tax withheld | 1,103 | $305.8K |
| Oct 5, 2026 | VETTER DAVID R Chief Legal Officer | Tax withheld | 734 | $203.5K |
| Oct 5, 2026 | Thompson Reyna President, North America | Tax withheld | 435 | $120.6K |
| Oct 5, 2026 | POLK DENNIS Chair, Hyve Solutions | Tax withheld | 1,212 | $336.1K |
| Oct 5, 2026 | Jordan David Gregory Chief Financial Officer | Tax withheld | 431 | $119.5K |
| Sep 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 300 | $80.2K |
| Sep 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 100 | $26.6K |
| Sep 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 400 | $105.7K |
| Sep 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 800 | $210.2K |
| Sep 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 700 | $184.4K |
| Sep 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 200 | $53.4K |
| Aug 17, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 500 | $132.2K |
| Aug 17, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 600 | $156.2K |
| Aug 17, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 200 | $52.7K |
| Aug 17, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 200 | $52.5K |
| Aug 17, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 500 | $129.8K |
| Aug 17, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 400 | $103.5K |
| Aug 17, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 100 | $26.2K |
| Aug 5, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 1,212 | $320.5K |
| Aug 5, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 635 | $166.7K |
| Aug 5, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 907 | $238.8K |
| Aug 5, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 173 | $44.8K |
| Aug 5, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 818 | $213.9K |
| Aug 5, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 668 | $174.0K |
| Aug 5, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 587 | $152.3K |
| Jul 31, 2026 | VEZINA ANN F Director | Sale | 1,273 | $326.0K |
| Jul 15, 2026 | Britt Douglas Director | Award | 629 | $0 |
| Jul 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 500 | $126.3K |
| Jul 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 268 | $66.9K |
| Jul 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 832 | $208.1K |
| Jul 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 200 | $49.5K |
| Jul 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 300 | $74.0K |
| Jul 15, 2026 | POLK DENNIS Chair, Hyve Solutions | Sale 10b5-1 plan | 400 | $99.4K |
| Jul 6, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 610 | $151.0K |
| Jul 6, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 336 | $82.1K |
| Jul 6, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 334 | $80.7K |
| Jul 6, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 1,124 | $270.4K |
| Jul 6, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 419 | $100.4K |
| Jul 6, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 224 | $53.3K |
| Jul 6, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 420 | $103.1K |
| Jul 6, 2026 | HUME RICHARD T Director | Sale 10b5-1 plan | 539 | $128.2K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for TD SYNNEX CORP
Free account. Everything above stays public.
Write why you follow TD SYNNEX CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading